Brandes Investment Partners LP increased its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD – Free Report) by 17.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 162,969 shares of the medical instruments supplier’s stock after buying an additional 24,604 shares during the period. Brandes Investment Partners LP owned about 4.81% of Utah Medical Products worth $10,018,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently added to or reduced their stakes in UTMD. Hotchkis & Wiley Capital Management LLC boosted its holdings in Utah Medical Products by 128.3% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 89,010 shares of the medical instruments supplier’s stock worth $5,956,000 after buying an additional 50,030 shares in the last quarter. Minerva Advisors LLC boosted its holdings in Utah Medical Products by 85.2% during the fourth quarter. Minerva Advisors LLC now owns 78,389 shares of the medical instruments supplier’s stock worth $4,819,000 after buying an additional 36,061 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in Utah Medical Products by 439.0% during the third quarter. Victory Capital Management Inc. now owns 14,408 shares of the medical instruments supplier’s stock worth $964,000 after buying an additional 11,735 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in Utah Medical Products by 838.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 11,698 shares of the medical instruments supplier’s stock worth $719,000 after acquiring an additional 10,452 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in Utah Medical Products by 9.6% during the third quarter. Geode Capital Management LLC now owns 97,080 shares of the medical instruments supplier’s stock worth $6,497,000 after acquiring an additional 8,516 shares during the last quarter. Hedge funds and other institutional investors own 69.60% of the company’s stock.
Utah Medical Products Trading Up 0.3 %
Shares of UTMD opened at $57.30 on Friday. The stock has a market cap of $194.36 million, a P/E ratio of 14.51 and a beta of 0.06. The company has a 50-day moving average of $60.58 and a two-hundred day moving average of $63.53. Utah Medical Products, Inc. has a 12-month low of $57.07 and a 12-month high of $77.33.
Utah Medical Products Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be given a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 2.13%. The ex-dividend date of this dividend is Friday, March 14th. Utah Medical Products’s payout ratio is currently 30.89%.
Utah Medical Products Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Read More
- Five stocks we like better than Utah Medical Products
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Election Stocks: How Elections Affect the Stock Market
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.